IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cellceutix Corp COM

Q4 2016 vs Q1 2017

Comparing institutional holders between quarters

Quarters

Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Ogorek Anthony Joseph
UNCHANGED
Shares300 from 300
Change0 (0%)
Value$0 ($0)
Filed 2017-04-19
Status
Ogorek Anthony Joseph
UNCHANGED30030000%$0$0$02017-04-19
Showing 1 of 1 institutions